List of redirects
Jump to navigation
Jump to search
Showing below up to 50 results in range #251 to #300.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
- Liver cancer → Hepatocellular carcinoma
- Lobaplatin → Lobaplatin (D-19466)
- Lomustine (Ceenu) → Lomustine (CCNU)
- Lorlatinib (PF-06463922) → Lorlatinib (Lorbrena)
- Lovenox → Enoxaparin (Lovenox)
- Lupron → Leuprolide (Lupron)
- Lutetium-177-PSMA-617 → Lutetium Lu 177 vipivotide tetraxetan (Pluvicto)
- MCL → Mantle cell lymphoma
- MDS → Myelodysplastic syndrome
- MLN9708 (MLN2238) → Ixazomib (Ninlaro)
- MOR208 → Tafasitamab (Monjuvi)
- MPDL3280A → Atezolizumab (Tecentriq)
- MSI-H or dMMR → Malignant solid neoplasm, MSI-H or dMMR
- MZL → Marginal zone lymphoma
- Mast cell diseases → Systemic mastocytosis
- Medroxyprogesterone (MPA) → Medroxyprogesterone acetate (MPA)
- Medullary thyroid cancer → Thyroid cancer, medullary
- Mepolizumab (Bosatria) → Mepolizumab (Nucala)
- Mercaptopurine (Purinethol) → Mercaptopurine (6-MP)
- Mesothelioma → Malignant pleural mesothelioma
- Midostaurin (PKC412) → Midostaurin (Rydapt)
- Mitapivat (AG-348) → Mitapivat (Pyrukynd)
- Mogamulizumab (KW-0761) → Mogamulizumab (Poteligeo)
- Momelotinib → Momelotinib (CYT-387)
- Momelotinib (CYT-387) → Momelotinib (Ojjaara)
- Moxetumomab pasudotox (HA22) → Moxetumomab pasudotox (Lumoxiti)
- Mycostatin (Nystatin) → Nystatin (Mycostatin)
- Myeloma → Multiple myeloma
- NEOD001 → Birtamimab (NEOD-001)
- NLPHL → Hodgkin lymphoma, nodular lymphocyte-predominant
- NSCLC → Non-small cell lung cancer
- NTRK → Malignant solid neoplasm, NTRK-mutated
- Naxitamab-gqgk (Danyelza) → Naxitamab (Danyelza)
- Necitumumab (IMC-11F8) → Necitumumab (Portrazza)
- Nelerabine (Arranon) → Nelarabine (Arranon)
- Neratinib (HKI-272) → Neratinib (Nerlynx)
- Neuroendocrine tumors → Neuroendocrine tumor
- Neutral → Vesicant & irritant chemotherapy
- Nintedanib (BIBF 1120) → Nintedanib (Vargatef)
- Niraparib (MK4827) → Niraparib (Zejula)
- Niraparib and Abiraterone (Akeega) → Niraparib and abiraterone (Akeega)
- Nirogacestat (PF-03084014) → Nirogacestat (Ogsiveo)
- Nivolumab (BMS-936558, MDX-1106) → Nivolumab (Opdivo)
- Non-small cell lung cancer, Nonsquamous → Non-small cell lung cancer, nonsquamous
- Non-small cell lung cancer, Squamous → Non-small cell lung cancer, squamous
- NovoTTF-100A device → NovoTTF-100A system (Optune)
- NovoTTF-100A device (Optune) → NovoTTF-100A system (Optune)
- Obinutuzumab (GA101) → Obinutuzumab (Gazyva)
- Octreotide LAR → Octreotide LAR (Sandostatin LAR)
- Oesophageal cancer → Esophageal cancer